1. Home
  2. DCTH vs ESEA Comparison

DCTH vs ESEA Comparison

Compare DCTH & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • ESEA
  • Stock Information
  • Founded
  • DCTH 1988
  • ESEA 2005
  • Country
  • DCTH United States
  • ESEA Greece
  • Employees
  • DCTH N/A
  • ESEA N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • ESEA Marine Transportation
  • Sector
  • DCTH Health Care
  • ESEA Consumer Discretionary
  • Exchange
  • DCTH Nasdaq
  • ESEA Nasdaq
  • Market Cap
  • DCTH 426.3M
  • ESEA 208.2M
  • IPO Year
  • DCTH N/A
  • ESEA 2006
  • Fundamental
  • Price
  • DCTH $11.03
  • ESEA $48.25
  • Analyst Decision
  • DCTH Strong Buy
  • ESEA Strong Buy
  • Analyst Count
  • DCTH 4
  • ESEA 1
  • Target Price
  • DCTH $24.00
  • ESEA $62.00
  • AVG Volume (30 Days)
  • DCTH 898.0K
  • ESEA 53.7K
  • Earning Date
  • DCTH 08-04-2025
  • ESEA 08-05-2025
  • Dividend Yield
  • DCTH N/A
  • ESEA 5.36%
  • EPS Growth
  • DCTH N/A
  • ESEA 21.86
  • EPS
  • DCTH N/A
  • ESEA 18.62
  • Revenue
  • DCTH $53,850,000.00
  • ESEA $222,525,034.00
  • Revenue This Year
  • DCTH $162.10
  • ESEA $7.22
  • Revenue Next Year
  • DCTH $32.97
  • ESEA $1.75
  • P/E Ratio
  • DCTH N/A
  • ESEA $2.61
  • Revenue Growth
  • DCTH 1068.87
  • ESEA 14.62
  • 52 Week Low
  • DCTH $7.17
  • ESEA $24.58
  • 52 Week High
  • DCTH $18.23
  • ESEA $50.82
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 34.31
  • ESEA 65.64
  • Support Level
  • DCTH $11.20
  • ESEA $46.59
  • Resistance Level
  • DCTH $12.72
  • ESEA $49.52
  • Average True Range (ATR)
  • DCTH 0.58
  • ESEA 1.76
  • MACD
  • DCTH -0.12
  • ESEA -0.07
  • Stochastic Oscillator
  • DCTH 22.18
  • ESEA 83.21

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

Share on Social Networks: